Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 5NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Lymphoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lung Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Liposarcoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Fibrosarcoma 5Neuroblastoma 4Hodgkin Disease 4Hemangiosarcoma 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malignant mesenchymal tumor 3Leukemia, Myeloid, Acute 3Hemangiopericytoma, Malignant 3Dendritic Cell Sarcoma, Interdigitating 3Central Nervous System Neoplasms 3Blast Crisis 3

Interventions

Carboplatin 50Paclitaxel 48Cisplatin 39Gemcitabine 31Erlotinib Hydrochloride 30Radiotherapy 28Docetaxel 24Taxes 21Specimen Handling 20Magnetic Resonance Spectroscopy 20Vinorelbine 16Pemetrexed 12Etoposide 12Bevacizumab 12Radiation 10Gefitinib 10aldesleukin 8Platinum 8Bortezomib 8Biopsy 8Vinblastine 7Azacitidine 71,2-diaminocyclohexaneplatinum II citrate 7pembrolizumab 6atezolizumab 6Observation 6Immunoglobulin G 6Disulfides 6Cyclophosphamide 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Carcinoma, Non-Small-Cell Lung × Ifosfamide × Clear all
NCT00003284 2014-01-06

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT00003240 2013-12-18

Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
1,800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003159 2013-12-04

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Completed
600 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004887 2013-09-20

Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery

National Cancer Institute (NCI)

Phase 3 Unknown
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡